Compare CWAN & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CWAN | HSIC |
|---|---|---|
| Founded | 2004 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 8.8B |
| IPO Year | 2021 | 1995 |
| Metric | CWAN | HSIC |
|---|---|---|
| Price | $24.13 | $76.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | $29.12 | ★ $76.50 |
| AVG Volume (30 Days) | ★ 13.0M | 1.1M |
| Earning Date | 02-18-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46826.67 | 30.70 |
| EPS | 1.40 | ★ 3.17 |
| Revenue | $640,376,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $64.93 | $5.35 |
| Revenue Next Year | $29.40 | $3.34 |
| P/E Ratio | ★ $17.21 | $24.24 |
| Revenue Growth | ★ 50.91 | 3.51 |
| 52 Week Low | $15.74 | $60.56 |
| 52 Week High | $32.00 | $82.49 |
| Indicator | CWAN | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 72.83 | 60.03 |
| Support Level | $24.05 | $75.65 |
| Resistance Level | $24.28 | $76.95 |
| Average True Range (ATR) | 0.36 | 1.10 |
| MACD | 0.08 | -0.29 |
| Stochastic Oscillator | 94.90 | 54.12 |
Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.